00 Acta Scientific | International Open Library | Open Access Journals Publishing Group

Acta Scientific Biotechnology

Editorial Volume 1 Issue 9

Rise in Drug-Resistant Pseudomonas aeruginosa Infections in Intensive Care Units

Mahendra Kumar Verma*

Centre for Molecular Biology Research, Bhopal, Madhya Pradesh, India

*Corresponding Author: Mahendra Kumar Verma, Centre for Molecular Biology Research, Bhopal, Madhya Pradesh, India.

Received: July 20, 2020; Published: August 01, 2020

×

 Pseudomonas aeruginosa is a gram-negative infectious agent to human remains associated with several diseases including urinary tract infections, respiratory system infections, dermatitis, soft tissue infections, bacteremia, bone and joint infections, gastrointestinal infections. The antibiotics use lead to control of bacterium growth and disease effectively. Recent studies have shown that new cases of Pseudomonas aeruginosa infections with higher frequency are reported worldwide. The growing concern worldwide is acquired drug resistance in Pseudomonas aeruginosa and the prevalence of such drug-resistant pathogens in intensive care units. The entire microbial world is evolved with unique genome plasticity and capacity to acquire additional gene/s as per need, including the drug resistance gene. It is now evident that extensive use of antibiotics and antimicrobial agents for a longer duration of time stimulated such pathogens for adaptation. The antibiotic pressure is selection criteria in microbial communities to alter genome by acquiring foreign DNA and or mutation in the genome itself. The entire microbial world is unique in having effective and robust enzyme/s capable of degradation of antibiotics and antimicrobial agents. Such capacity allows microbes to grow in hearse conditions as well. This is one of the possible mechanisms behind the rise of new cases of Pseudomonas aeruginosa in Intensive Care Units.

×

Citation

Citation: Mahendra Kumar Verma. “Rise in Drug-Resistant Pseudomonas aeruginosa Infections in Intensive Care Units". Acta Scientific Biotechnology 1.9 (2020): 01-02.




Metrics

Acceptance rate36%
Acceptance to publication20-30 days

Indexed In


News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is October 20, 2021.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US